Trademark: 97703809
Word
CANCER ZERO
Status
Pending
Status Code
688
Status Date
Tuesday, March 12, 2024
Serial Number
97703809
Mark Type
4000
Filing Date
Monday, December 5, 2022
Published for Opposition
Tuesday, January 16, 2024

Trademark Owner History
IN8bio, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations, namely, oncological preparations; reagent, diagnostic and therapeutic preparations for medical use in oncology; targeted medical preparations for use in oncology; pharmaceutical preparations for use in the treatment of cancer and tumors; pharmaceutical and medicinal preparations for the treatment of cancer and oncological conditions; pharmaceutical and biological preparations for use in immunotherapies to improve immune system function; pharmaceutical and biological preparations combining immunotherapies and chemotherapies for treatments in the field of oncology; medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of immunological and oncological diseases and disorders; pharmaceutical and biological preparations comprised of modified t cells used for multiple modes of treatment against tumor resistance and immunosuppression; pharmaceuticals in the nature of cell therapeutics for the treatment and prevention of cancer; engineered cell therapies, namely, engineered T cells, immune cells, and antibodies for the treatment and prevention of cancer
44 Medical services; Providing health information; Providing health information in the field of bioengineering and genetic engineering; Providing health information in the field of autoimmune, inflammatory and infectious diseases and disorders, cancer prevention and treatment; Medical diagnosis and treatment of cancer, autoimmune, inflammatory, and infectious diseases and disorders
42 Research, development, and evaluation of new products; pharmaceutical, medicine, and vaccine research and development services; technical research in the field of pharmaceutical studies; laboratory analysis and research into new drugs and pharmaceutical products; development of scientific measuring and testing methods in the field of oncology; design, development, research, and conducting clinical trials for others in connection with drugs, pharmaceuticals, and cellular therapies for the treatment and/or prevention of cancer; research and development services in the fields of oncology, immunotherapy, chemotherapy and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice and consultancy in the field of oncology; research and development in the field of bioengineering and genetic engineering; Research and development of treatments and therapies in the field of oncology; Research and development of pharmaceuticals for the treatment and prevention of cancer, autoimmune, inflammatory, and infectious diseases and disorders; Scientific research for medical purposes in the field of cancer, autoimmune, inflammatory, and infectious diseases and disorders; Molecular, cellular, and genetic research and development; Development of processes and methods for the manufacturing and engineering of cells and molecules; development of therapeutics and treatments for the prevention of cancer, autoimmune, inflammatory, genetic and infectious diseases and disorders; Development of diagnostic medical measuring and testing methods in the field of cancer therapy and treatment
"CANCER"

Trademark Events
Mar 12, 2024
Noa E-Mailed - Sou Required From Applicant
Jan 16, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 16, 2024
Published For Opposition
Dec 27, 2023
Notification Of Notice Of Publication E-Mailed
Dec 13, 2023
Approved For Pub - Principal Register
Dec 12, 2023
Teas/Email Correspondence Entered
Dec 11, 2023
Correspondence Received In Law Office
Dec 11, 2023
Teas Response To Office Action Received
Oct 23, 2023
Notification Of Non-Final Action E-Mailed
Oct 23, 2023
Non-Final Action E-Mailed
Oct 23, 2023
Non-Final Action Written
Oct 23, 2023
Previous Allowance Count Withdrawn
Oct 3, 2023
Withdrawn From Pub - Og Review Query
Sep 19, 2023
Approved For Pub - Principal Register
Sep 19, 2023
Examiner's Amendment Entered
Sep 19, 2023
Notification Of Examiners Amendment E-Mailed
Sep 19, 2023
Examiners Amendment E-Mailed
Sep 19, 2023
Examiners Amendment -Written
Sep 12, 2023
Assigned To Examiner
Jan 3, 2023
New Application Office Supplied Data Entered
Dec 8, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24